Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1996-12-12
Original market date: See footnote 1
1959-12-31
Product name:
REVERIN 275MG
DIN:
00012521 Electronic product monograph is not available
Company:
HOECHST CANADA INC.
2150 Boul. St-Elzear Ouest
Laval
Quebec
Canada
H7L 4A8
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intrapleural , Intra-Articular , Intraperitoneal , Intravenous , Intrathecal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.24
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01AA09 ROLITETRACYCLINE
Active ingredient group (AIG) number:See footnote5
0105551001
Active ingredient(s) | Strength |
---|---|
ROLITETRACYCLINE | 275 MG / VIAL |